Aurinia to Participate in Upcoming Investor Healthcare Conferences

Rhea-AI Summary

Aurinia Pharmaceuticals (NASDAQ: AUPH) announced participation in key investor healthcare conferences. The management team will engage in one-on-one meetings with investors at the Leerink Partners Therapeutics Forum in Boston on July 9-10, 2024. Additionally, they will attend the 3rd Annual H.C. Wainwright Virtual Kidney Conference on July 15, 2024. These events aim to foster investor relations and provide updates on Aurinia's therapeutic advancements.

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the Company’s management team will participate in one-on-one meetings with investors at the Leerink Partners Therapeutics Forum: I&I and Metabolism, July 9-10, 2024, in Boston, and at the 3rd Annual H.C. Wainwright Virtual Kidney Conference, July 15, 2024.

About Aurinia

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS^® (voclosporin), the first FDA-approved oral therapy dedicated to the treatment of adult patients with active lupus nephritis. The Company’s head office is in Edmonton, Alberta, its U.S. commercial office is in Rockville, Maryland. The Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240702079714/en/

Media and Investor Inquiries:

Andrea Christopher

Corporate Communications and Investor Relations, Aurinia

achristopher@auriniapharma.com

ir@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

What upcoming conferences will Aurinia Pharmaceuticals (AUPH) participate in?

Aurinia Pharmaceuticals (AUPH) will participate in the Leerink Partners Therapeutics Forum in Boston on July 9-10, 2024, and the 3rd Annual H.C. Wainwright Virtual Kidney Conference on July 15, 2024.

When is Aurinia Pharmaceuticals (AUPH) attending the Leerink Partners Therapeutics Forum?

Aurinia Pharmaceuticals (AUPH) will attend the Leerink Partners Therapeutics Forum on July 9-10, 2024, in Boston.

When is Aurinia Pharmaceuticals (AUPH) attending the H.C. Wainwright Virtual Kidney Conference?

Aurinia Pharmaceuticals (AUPH) will attend the H.C. Wainwright Virtual Kidney Conference on July 15, 2024.

What is the focus of Aurinia Pharmaceuticals' (AUPH) participation in upcoming conferences?

Aurinia Pharmaceuticals' (AUPH) participation focuses on engaging with investors and discussing therapeutic advancements at the Leerink Partners Therapeutics Forum and the H.C. Wainwright Virtual Kidney Conference in July 2024.

How is Aurinia Pharmaceuticals (AUPH) engaging with investors in July 2024?

Aurinia Pharmaceuticals (AUPH) will participate in one-on-one meetings with investors during the Leerink Partners Therapeutics Forum on July 9-10 and the H.C. Wainwright Virtual Kidney Conference on July 15, 2024.